The oncology and rare diseases data and insights platform.
MediSights
captures what doctors really think and do—then turns it into evidence-linked decisions your teams can verify. Built for pharma compliance from day one.
Doctors say one thing. Data suggests another. What do you trust?
In oncology and rare diseases, evidence evolves fast and decision-making is full of trade-offs. Even when good insights exist, they sit in static decks, stay with small teams, and rarely become tools your organization can use daily.Most pharma teams can't answer:
Most pharma teams can't answer:
What do doctors really believe about our brand vs competitors?
How are treatment patterns shifting across markets?
Did our last initiative actually change prescribing behavior?
MediSights helps you get to the truth- and make it useful.
MediSights turns real doctor conversations into an always-on decision system for oncology and rare-disease pharma teams
We help pharma get to truth-tested decisions - fast- by grounding insights in real world evidence.
Capture
Deep conversations with oncologists and rare disease specialists worldwide. We go beyond surveys to understand beliefs, trade-offs, and real-world decision-making.
Analyze
AI-powered analysis that organizes doctor intelligence into insights you can explore and verify. Every finding links back to the underlying evidence.
Activate
Insights formatted for how pharma actually works: brand planning, CRM systems, commercial workflows, and field execution.
Built for pharma compliance
Security, privacy, adverse event detection, pharma-grade auditability. Clinical ontologies for oncology and rare diseases prevent AI hallucinations.